These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

207 related items for PubMed ID: 8320963

  • 1. Xenogeneic PBL-scid mice: their potential and current limitations.
    Greenwood JD.
    Lab Anim Sci; 1993 Apr; 43(2):151-5. PubMed ID: 8320963
    [Abstract] [Full Text] [Related]

  • 2. A model of human anti-T-cell monoclonal antibody therapy in SCID mice engrafted with human peripheral blood lymphocytes.
    Tsuchida M, Brown SA, Tutt LM, Tan J, Seehafer DL, Harris JP, Xun CQ, Thompson JS.
    Clin Transplant; 1997 Oct; 11(5 Pt 2):522-8. PubMed ID: 9361954
    [Abstract] [Full Text] [Related]

  • 3. Human peripheral blood lymphocyte reconstituted severe combined immunodeficient (hu-PBL-SCID) mice. A model for human islet allograft rejection.
    Shiroki R, Poindexter NJ, Woodle ES, Hussain MS, Mohanakumar T, Scharp DW.
    Transplantation; 1994 Jun 15; 57(11):1555-62. PubMed ID: 8009588
    [Abstract] [Full Text] [Related]

  • 4. Engraftment of human peripheral blood leukocytes into severe combined immunodeficient mice results in the long term and dynamic production of human xenoreactive antibodies.
    Williams SS, Umemoto T, Kida H, Repasky EA, Bankert RB.
    J Immunol; 1992 Oct 15; 149(8):2830-6. PubMed ID: 1401915
    [Abstract] [Full Text] [Related]

  • 5. Specific antibody production to a recall or a neoantigen by SCID mice reconstituted with human peripheral blood lymphocytes.
    Nonoyama S, Smith FO, Ochs HD.
    J Immunol; 1993 Oct 01; 151(7):3894-901. PubMed ID: 8376809
    [Abstract] [Full Text] [Related]

  • 6. The fate of human peripheral blood lymphocytes after transplantation into SCID mice.
    Martino G, Anastasi J, Feng J, Mc Shan C, DeGroot L, Quintans J, Grimaldi LM.
    Eur J Immunol; 1993 May 01; 23(5):1023-8. PubMed ID: 8477797
    [Abstract] [Full Text] [Related]

  • 7. SCID-hu-PBL: a model for making human antibodies?
    Ifversen P, Borrebaeck CA.
    Semin Immunol; 1996 Aug 01; 8(4):243-8. PubMed ID: 8883147
    [Abstract] [Full Text] [Related]

  • 8. [Development of HPV16 positive cervical cancer model in the hu-PBL-SCID mouse and its immunological features].
    Liang ZX, Cheng Q, Chen HZ, Xie X, Ye DF.
    Zhonghua Yi Xue Za Zhi; 2004 Sep 02; 84(17):1465-9. PubMed ID: 15500747
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The SCID mouse.
    Pla M, Mahouy G.
    Nouv Rev Fr Hematol (1978); 1991 Sep 02; 33(6):489-91. PubMed ID: 1818304
    [Abstract] [Full Text] [Related]

  • 11. The use of the hu-PBL-SCID mouse model to study lymphocyte homing and responsiveness to recall antigens.
    Lue C, Kiyono H, Fujihashi K, McGhee JR, Mestecky J.
    Reg Immunol; 1992 Sep 02; 4(2):86-90. PubMed ID: 1503891
    [Abstract] [Full Text] [Related]

  • 12. SCID mouse as a model for transplantation studies.
    Renz JF, Lin Z, de Roos M, Dalal AA, Ascher NL.
    J Surg Res; 1996 Sep 02; 65(1):34-41. PubMed ID: 8895604
    [Abstract] [Full Text] [Related]

  • 13. A human model of xenogeneic graft-versus-host disease in SCID mice engrafted with human peripheral blood lymphocytes.
    Sandhu JS, Gorczynski R, Shpitz B, Gallinger S, Nguyen HP, Hozumi N.
    Transplantation; 1995 Jul 27; 60(2):179-84. PubMed ID: 7624960
    [Abstract] [Full Text] [Related]

  • 14. SCID mouse models of human stem cell engraftment.
    Greiner DL, Hesselton RA, Shultz LD.
    Stem Cells; 1998 Jul 27; 16(3):166-77. PubMed ID: 9617892
    [Abstract] [Full Text] [Related]

  • 15. The huPBL-SCID mouse as a means to examine human immune function in vivo.
    Murphy WJ, Taub DD, Longo DL.
    Semin Immunol; 1996 Aug 27; 8(4):233-41. PubMed ID: 8883146
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Viral pathogenesis in hu-PBL-SCID mice.
    Mosier DE.
    Semin Immunol; 1996 Aug 27; 8(4):255-62. PubMed ID: 8883149
    [Abstract] [Full Text] [Related]

  • 18. The human immune system in hu-PBL-SCID mice.
    Tary-Lehmann M, Saxon A, Lehmann PV.
    Immunol Today; 1995 Nov 27; 16(11):529-33. PubMed ID: 7495490
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Type I interferon is a powerful inhibitor of in vivo HIV-1 infection and preserves human CD4(+) T cells from virus-induced depletion in SCID mice transplanted with human cells.
    Lapenta C, Santini SM, Proietti E, Rizza P, Logozzi M, Spada M, Parlato S, Fais S, Pitha PM, Belardelli F.
    Virology; 1999 Oct 10; 263(1):78-88. PubMed ID: 10544084
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.